Elevations in serum alanine aminotransferase (ALT)

Also known as: Increases in ALT / Increased SGPT (ALT) / Increases in serum alanine aminotransferase / Elevated alanine aminotransferase (ALT) / Increased ALT/SGPT / Increased serum ALT / Elevated Alanine Aminotransferase Levels / Elevated ALT levels / Increases in ALT/SGPT / Increased serum alanine aminotransferase (ALT) / Abnormal ALT levels / Elevated alanine aminotransferase (ALT/SGPT) / Elevation in alanine aminotransferase / Elevations of ALT (SGPT) / Elevation in alanine transaminase / Increased levels of ALT / Increased SGPT / Elevated alanine aminotransaminase / Increased alanine aminotransferase / Elevated SGPT/ALT / Increases in alanine aminotransferase (ALT/SGPT) / Increased ALT (SGPT) / Elevation of ALT levels / Elevated ALT / Increase in alanine aminotransferase / Elevated serum alanine aminotransferase / Abnormal ALT / SGPT elevation / Increase in ALT / Elevated alanine aminotransferase / Increased ALT / Elevations in SGPT / Increase in SGPT / Elevated SGPT / Elevations in SGPT enzyme levels / Increased serum alanine aminotransferase / High alanine transaminase / Increased alanine transaminase / Elevation of ALT / Elevated alanine transaminase / Abnormalities in ALT / Elevated alanine transaminase (ALT) / Increased alanine aminotransferase (ALT) / Elevated serum ALT / Increase in alanine transaminase / Elevations in ALT / Abnormalities in alanine transaminase (ALT) / SGPT increased / Alanine aminotransferase increase / Alanine aminotransferase increased / Alanine aminotransferase (serum glutamic-pyruvic transaminase) level raised (finding) / ALT increased / Serum glutamic-pyruvic ta increased / GPT inc / GPT increased / Glutamic-pyruvate transaminase increased / Transaminase glutamic-pyruvic increased / Glutamic-pyruvic transaminase increased / Glutamic-pyruvic transam incr / Serum glutamic-pyruvic transaminase increased / Serum glutamic-pyruvic ta incr

DrugDrug NameDrug Description
DB06683ClevudineInvestigated for use/treatment in hepatitis (viral, B).
DB00008Peginterferon alfa-2aA modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses.
DrugDrug NamePhaseStatusCount
DB01265Telbivudine4Completed1